Second-generation mRNA COVID-19 vaccine candidate, CV2CoV, demonstrates improved immune response and… EP News Bureau Aug 18, 2021 Pre-clinical study provides evidence for improved immune responses with second-generation mRNA backbone jointly developed by…
Clover and GSK announce research collaboration to evaluate coronavirus (COVID-19) vaccine candidate… EP News Bureau Feb 26, 2020 Having one of the largest in-house, commercial-scale cGMP biomanufacturing capabilities in China, Clover could potentially rapidly…
